ABAB Pedia

Ben Lamm

Overview

Ben Lamm is co-founder and CEO of Colossal Biosciences. Earlier ventures include Chaotic Moon, Team Chaos, Conversable and Hypergiant. His career expanded from software and digital experiences into AI and conservation biotechnology, with a business leadership role at Colossal.⁠[1]

Contents25 sections
Key facts

Baylor and Simply Interactive

Lamm earned a BBA from Baylor University in 2004. While studying, he developed a class project into Simply Interactive, offering interactive marketing and e-learning services. A university alumni profile reported a six-figure contract with its first client.⁠[2]

Founding Chaotic Moon

In 2010, Lamm co-founded Austin-based Chaotic Moon and served as CEO. The studio worked on digital-product design, prototypes and user experiences, combining software development with experimental products.⁠[3]

Accenture acquires Chaotic Moon

On July 22, 2015, Accenture announced its acquisition of Chaotic Moon to expand digital design and innovation capabilities. The announcement identified Lamm as co-founder and CEO; financial terms were not disclosed.⁠[3]

Team Chaos and games

Lamm and Andrew Busey co-founded game company Team Chaos. Baylor’s alumni publication records its acquisition by Zynga in 2016.⁠[4]

Founding Hypergiant

Lamm founded Hypergiant in 2018, extending his work in artificial intelligence. The company later focused on decision-support and situational-awareness software for defense, space and critical infrastructure.⁠[5]

LivePerson acquires Conversable

On October 1, 2018, LivePerson announced its acquisition of Conversable, co-founded by Lamm and Andrew Busey. Lamm was CEO. Conversable helped businesses automate conversations across messaging and voice channels, and its team joined LivePerson.⁠[6]

Meeting George Church

According to the Wyss Institute’s project account, Lamm visited George Church’s laboratory in 2019. Their contact led toward the collaboration behind Colossal, combining Church’s genomics research with Lamm’s experience building companies.⁠[7]

Launching Colossal

On September 13, 2021, Colossal launched with $15 million in seed funding, Lamm as CEO and Church among its co-founders. It established sponsored-research and licensing arrangements with Harvard. An initial objective was a cold-adapted animal with mammoth traits developed through Asian-elephant research, a research goal rather than an accomplished mammoth revival.⁠[8]

Spinning out Form Bio

On September 27, 2022, Colossal announced the spinout of Form Bio and its $30 million Series A. Lamm was a co-founder, while Andrew Busey and Kent Wakeford were co-CEOs. The business commercialized tools for computational-biology data processing, analysis and workflows.⁠[9]

Trive Capital acquires Hypergiant

An August 22, 2023 announcement disclosed Trive Capital’s acquisition of Hypergiant to support its AI software business. Mike Betzer was the company’s CEO at that point; Lamm commented as its founder.⁠[5]

Co-founding Breaking

Breaking, launched in 2024, grew from technology developed through the Wyss Institute and Colossal. Lamm is among its founders. It develops microbial approaches to plastic pollution, extending biotechnology commercialization into environmental remediation.⁠[10][11]

The woolly-mouse experiment

On March 4, 2025, Colossal announced woolly mice produced through eight edits involving seven genes, altering coat-related traits. It presented the work as a model for multiplex editing and mammoth-associated characteristics. The animals remained mice; the experiment did not establish mammoth revival.⁠[12]

The dire-wolf announcement

On April 7, 2025, Colossal announced three pups named Romulus, Remus and Khaleesi, calling them revived dire wolves. Its account described 20 edits across 14 genes in gray-wolf cells, followed by cloning and domestic-dog surrogacy. Specialist criticism challenged the species designation and conservation implications.⁠[13][14]

Canid specialists’ objections

On April 18, 2025, the IUCN SSC Canid Specialist Group characterized the animals as genetically modified gray wolves, not dire wolves or established conservation proxies. It acknowledged potential technical uses but argued that appearance alone did not demonstrate ecological function or conservation benefit, emphasizing living species and their habitats.⁠[14]

Expanded funding and dodo research

In September 2025, Colossal announced $120 million in additional funding, bringing the round to $320 million and cumulative funding above $555 million, at a disclosed $10.32 billion valuation. Dodo-project updates included pigeon primordial-germ-cell culture and potential surrogate chickens. These were experimental-platform advances, not the birth of living dodos.⁠[15]

Acquiring Viagen

In November 2025, Colossal announced its acquisition of Viagen Pets and Equine, a provider of animal genetic preservation and cloning services. Viagen became a wholly owned subsidiary with its existing leadership, supporting Colossal’s intended expansion in endangered-species cloning.⁠[16]

A conservation framework with the U.S. Interior Department

On June 25, 2026, the U.S. Department of the Interior announced a collaboration framework with Colossal involving the Fish and Wildlife Service, biobanking and conservation genomics. The memorandum did not itself obligate federal funds; specific projects required separate arrangements.⁠[17]

Appearing at Moonshots Live

Lamm joined a Moonshots Live discussion recorded on September 25, 2026 and published on September 30. The official episode page and video description list AI, biology, gene editing and species conservation among its subjects, alongside Peter Diamandis, Salim Ismail, Dave Blundin and Alex Wissner-Gross.⁠[18][19]

Astromech and biological AI

Astromech names Lamm and George Church among its founding members. It proposes a Large Life Model integrating biological data across species to investigate genotype–phenotype relationships. The website describes a development program, rather than demonstrated general predictive mastery of biology.⁠[20]

Colossal’s response to the controversy

In its document addressing IUCN guidance, Colossal describes dire-wolf proxies and acknowledges genetic, phenotypic and possible behavioral differences from the extinct species. It states there is no current plan for wild release and argues that the work can support genetic rescue and reproductive technology for living canids. This is the company’s assessment, not IUCN endorsement.⁠[21]

Conservation and nonprofit activity

The Colossal Foundation is Colossal’s nonprofit arm, applying genetic engineering, biobanking and AI monitoring to wildlife conservation. Linked to the company’s technology development, its work emphasizes collaboration with conservationists and local communities to move research into field projects.⁠[22]

Public organizational roles

As checked in October 2026, The Planetary Society lists Lamm on its Advisory Council, The Explorers Club lists him as a trustee, and the National Fish and Wildlife Foundation lists him as a director. These are distinct roles confirmed by the respective organizations.⁠[23][24][25]

Public accounts

Sources

  1. Company — Ben Lamm (opens in a new window)
  2. Ben Lamm, BBA 2004 (opens in a new window)
  3. Accenture Acquires Chaotic Moon to Continue Growing Its Digital Design and Innovation Capabilities (opens in a new window)
  4. Alumni News — Spring 2019 (opens in a new window)
  5. Hypergiant Industries Partners with Trive Capital (opens in a new window)
  6. LivePerson acquires Conversable (opens in a new window)
  7. Biotechnology for conservation and de-extinction (opens in a new window)
  8. Colossal Biosciences Launches with $15M Seed Funding (opens in a new window)
  9. Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences (opens in a new window)
  10. Startups and Licensing — Breaking (opens in a new window)
  11. Breaking — founders and technology (opens in a new window)
  12. Colossal Creates the Colossal Woolly Mouse (opens in a new window)
  13. Colossal Dire Wolves: Brought Back from 12,000-Year Extinction Through Revolutionary Gene Editing (opens in a new window)
  14. Conservation perspectives on gene-editing in wild canids (opens in a new window)
  15. Colossal Advances Dodo De-Extinction and Secures an Additional $120M in Funding (opens in a new window)
  16. Colossal Biosciences Acquires Viagen, the Leader in Animal Cloning (opens in a new window)
  17. Interior and Colossal Biosciences Announce Conservation Collaboration (opens in a new window)
  18. Anthropic’s Wet Lab, Artificial Wombs in 24 Months, and Scalable Gene Editing | MOONSHOTS Live #297 (opens in a new window)
  19. Why We’re Living in a Biological Singularity (opens in a new window)
  20. Astromech — Large Life Model (opens in a new window)
  21. Alignment of Colossal’s Dire Wolf De-Extinction Project with IUCN SSC Guiding Principles (opens in a new window)
  22. About Us — Colossal Foundation (opens in a new window)
  23. Advisory Council — Ben Lamm (opens in a new window)
  24. Club Officials — Board of Trustees (opens in a new window)
  25. Board of Directors — Ben Lamm (opens in a new window)